• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
ACXP

ACXP

Acurx Pharmaceuticals, Inc.

NASDAQHealthcareBiotechnologyUS

USD1.75

-0.05 (-2.78%)

Rating:C+

Company Profile

CEO

David Luci

IPO Date

2021-06-25

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$1.88

Prev. Close

$1.80

Day Low

$1.74

Day High

$1.89

52W Low

$1.33

52W High

$21.00

Market Cap

$0.00B

Volume

0.11M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

3

Avg Positive

31.7%

Avg Negative

2.3%

Avg Neutral

66.0%

News Feed

Acurx Pharmaceuticals to Discuss 2021 Second Quarter Financial Results on August 17, 2021 Conference Call and Provide Business Update

PRNewsWire·7/28/2021·↑ positive

Acurx Announces New Ibezapolstat Data on Anti-Recurrence Mechanisms in CDI at Prominent International Conference

PRNewsWire·7/1/2021·↑ positive

ACURX PHARMACEUTICALS, Inc. Announces Closing of INITIAL Public Offering OF common stock AND FULL EXERCISE OF UNDERWRITERS' OPTION TO PURCHASE ADDITIONAL SHARES

PRNewsWire·6/29/2021·↑ positive